When is paying patent excess claims fees excessive in Australia and New Zealand?
Introduction In 2020, both IP Australia and the Intellectual Property Office of New Zealand (“IPONZ”) introduced updated fee schedules, with new fee structures impacting the payment of excess claims fees....
Introduction In 2020, both IP Australia and the Intellectual Property Office of New Zealand (“IPONZ”) introduced updated fee schedules, with...
Read More
TGA proposes far-reaching changes to support the repurposing of prescription medicines
The Therapeutic Goods Administration (TGA) has commenced a timely public consultation into the repurposing of prescription medicines, which seeks to better understand the incentives and potential hurdles influencing sponsors’...
The Therapeutic Goods Administration (TGA) has commenced a timely public consultation into the repurposing of prescription medicines, which seeks...
Read More
A bar to re-examination
In Australia, there are different options to challenge the validity of a patent application or granted patent.  This can be of significant interest from a freedom to operate perspective...
In Australia, there are different options to challenge the validity of a patent application or granted patent.  This can...
Read More
2021: An AI Inventor Odyssey
As part of a global series of cases testing the boundaries of what it means to be an inventor, the Australian Patent Office ("APO") has now had its say...
As part of a global series of cases testing the boundaries of what it means to be an inventor,...
Read More
Pfizer preliminary discovery attempt on ERELZI fails
In this Federal Court case, Pfizer’s attempt to obtain documentation from Sandoz regarding its ERELZI etanercept product failed, Justice Burley finding that undertakings provided by Sandoz to give notice...
In this Federal Court case, Pfizer’s attempt to obtain documentation from Sandoz regarding its ERELZI etanercept product failed, Justice...
Read More